NCT00216151 - Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions

Multiple Myeloma

Interventions

DRUG

Zoledronic Acid

Zoledronic Acid 4mg, every three months

Trial Locations (8)

Indiana University Cancer Center, Indianapolis

Quality Cancer Center (MCGOP), Indianapolis

Elkhart Clinic, Elkhart

Northern Indiana Cancer Research Consortium, South Bend

Oncology Hematology Associates of SW Indiana, Evansville

Providence Medical Group, Terre Haute

AP&S Clinic, Terre Haute

Arnett Cancer Care, Lafayette